Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263481 · ClinicalTrials.gov registry record · NA
Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03263481 is a NA study that has completed, run by Indiana University. The registered enrollment target is 8 participants.
The verdict
NCT03263481, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The aim is to evaluate the peak secretory flow rates and bicarbonate concentrations as determined by a 30 minute intraductal secretin stimulation test in patients with a low likelihood of pancreatic pathology and to compare these data to those obtained from our historical patients with suspected chronic pancreatitis. These will be patients in which inadvertent pancreatic cannulation occurs during therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for biliary indications . All study subjects will receive a 5 day follow-up phone call. Enrollment goal is 36 subjects.
Interventions
- PROCEDURE Intraductal secretin test (IDST)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2023-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03263481
The ClinicalTrials.gov registry entry for NCT03263481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intraductal secretin test (IDST) is the first listed.
NCT03263481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03263481 about?
NCT03263481 is a clinical study titled "Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?". The aim is to evaluate the peak secretory flow rates and bicarbonate concentrations as determined by a 30 minute intraductal secretin stimulation test in patients with a low likelihood of pancreatic pathology and to compare these data to those obtained from our historical patients with suspected chr...
What is the current status of trial NCT03263481?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2017-09-01. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT03263481?
The interventions under investigation include: Intraductal secretin test (IDST) (PROCEDURE).
Who is sponsoring clinical trial NCT03263481?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.